Redicarpet

About Craig McCartydivider
The McCarty Cancer Foundation was established in 1997 by NHL star Darren McCarty as a Father's Day gift to his father Craig, who was diagnosed with multiple myeloma in 1995. Sadly, Craig lost his battle on November 24th, 1999.

With Darren's relentless efforts and those of many devoted individuals, the McCarty Cancer Foundation is dedicated to raising awareness of multiple myeloma and improving the quality of life of myeloma cancer patients while working toward prevention and a cure.

The Foundation is a non-profit corporation under the leadership of an appointed Board of Directors , as well as the guidance of an expert scientific advisory board.

The specific goal of the McCarty Cancer Foundation is to raise funds to finance research which offers significant promise in the search for a cure of this terminal cancer. Money is raised from charitable donations, raffles, and other similar fund-raising events.

Together, with everyone's support, a cure will be found.











home / Frequently Asked Questions
divider

Frequently Asked Questions


What is our mission?
The McCarty Cancer Foundation was created by NHL star, Darren McCarty. With Darren's relentless efforts and those of many devoted individuals, the McCarty Cancer Foundation is dedicated to raising awareness of multiple myeloma and improving the quality of life of myeloma cancer patients, while working toward prevention and a cure.

The Foundation is a non-profit corporation under the leadership of an appointed Board of Directors, as well as the guidance of an expert advisory board. Our specific goal is to raise funds to finance research which offers significant promise in the search for a cure of this terminal cancer. Money will be raised from charitable donations, raffles, and other similar fund-raising events. In addition, competitive grants will be awarded to researchers actively working in the field of multiple myeloma.

What are scientific advisors?
Scientific advisors work with the Foundation to identify research opportunities which offer the greatest promise in treating multiple myeloma. The advisors will also review progress on research programs for which the Foundation grants have been made. The advisors were selected based on their knowledge, experience and dedication in the field of multiple myeloma.

• Craig Webb, Principal Investigator, Laboratory of Tumor and Angiogenesis Director, Multiple Myeloma Laboratory - Van Andel Institute
• Dr. Keith Stewart, MD, ChB, Professor - Mayo Clinic
• Dr. Jeffrey Zonder, MD, Assistant Professor, Division of Hematology/Oncology, Wayne State University School of Medicine - Karmanos Cancer Institute